Adjusting natriuretic peptide decision limits for BMI for a more personalized diagnosis of heart failure

Gruson, Damien;Bernardini, Sergio;Perrone, Marco
(2025) Advances in Laboratory Medicine / Avances en Medicina de Laboratorio — Vol. 6, n° 3, p. 373-374 (2025)

Files

2025_Gruson_Adv_Lab_Med_373-374.pdf
  • Open Access
  • Adobe PDF
  • 148.85 KB
  • https://creativecommons.org/licenses/by/4.0/
Download

Details

Authors
  • Gruson, DamienUCLouvain
    Author
  • Bernardini, Sergioorcid-logoDepartment of Experimental Medicine , University of Rome Tor Vergata , Rome , Italy
    Author
  • Perrone, Marcoorcid-logoDepartment of Clinical Sciences and Translational Medicine , University of Rome Tor Vergata , Rome , Italy
    Author
Abstract
(en) To the Editor, Heart failure (HF) continues to pose significant challenges globally, with natriuretic peptides playing pivotal roles in its diagnosisandmanagement.Thesebiomarkersarecrucial in distinguishing cardiac from non-cardiac causes of dyspnea, for the risk evaluation of HF patients and in monitoring therapeutic efficacy. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Gruson, D., Bernardini, S., & Perrone, M. (2025). Adjusting natriuretic peptide decision limits for BMI for a more personalized diagnosis of heart failure. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 6(3), 373-374. https://doi.org/10.1515/almed-2025-0020 (Original work published 2025)